黄素对降低2型糖尿病肥胖患者的异质风险的影响:一项随机对照试验
Metha Yaikwawong1, Laddawan Jansarikit1, Siwanon Jirawatnotai1,2,3
1Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
黄素补充剂显著降低了脉冲波速度,并改善了2型糖尿病肥胖患者的心脏代谢风险标志物. 这表明,黄素可以有效降低异位风险.
科学领域:
- 营养科学 营养科学
- 心血管研究研究心血管研究
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 黄是一种来自黄的化合物,具有抗炎性质.
- 肥胖和2型糖尿病是诸如动脉样硬化等心血管并发症的重要危险因素.
- 炎症在动脉样硬化发展中起着关键作用.
研究的目的:
- 调查黄素在减轻动脉动脉发生风险方面的疗效.
- 评估黄素对肥胖2型糖尿病患者脉冲波速度和代谢概况的影响.
主要方法:
- 一个为期12个月的随机,双盲,安慰剂对照试验,涉及227名参与者.
- 评估脉冲波速率,脂质样本 (LDL-C,sdLDL-C) 和炎症标志物 (hs-CRP,IL-1β,IL-6,TNF-α). 进行评估.
- 在基线和3,6,9和12个月间隔进行的测量.
主要成果:
- 治疗黄素导致脉冲波速度显著降低 (p < 0.001).
- 在LDL-C,sdLDL-C,hs-CRP,IL-1β,IL-6和TNF-α (所有p <0.001) 中观察到显著下降.
- 库尔库明组明显改善了心脏代谢风险概况.
结论:
- 黄素的干预有效地降低了脉冲波速度,改善了心脏代谢风险因素.
- 黄素治疗显示,有望降低2型糖尿病肥胖个体的风险.
- 这些发现支持黄素作为心血管风险管理的治疗剂的潜力.
更多相关视频
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Obesity
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
